loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 205596 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 MERCK SHARP DOHME (1)

filter

01 SOLUTION;INTRAVENOUS (1)

filter

01 RX (1)

filter

01 NOXAFIL (1)

filter

01 Yes (1)

URL Supplier Web Content
SOLUTION; INTRAVEN...
300MG/16.7ML (18MG...
2014-03-13
205596
NOXAFIL
RX
Yes
AP
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 205596

Looking for FDA Orange Book APPLICATION 205596 1

19

Merck & Co, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is POSACONAZOLE, with a corresponding application number 205596.

Regulatory Information RX

With a dosage strength 300MG/16.7ML (18MG/ML)

Dosage Form Route SOLUTION; INTRAVENOUS

Reference Listed Drug Yes

Approved since 2014-03-13

Therapeutic Equivalence (TE) Code AP

Post Enquiry
POST ENQUIRY